NCT06238479 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT06238479
Title	A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors
Recruitment	Recruiting
Gender	both
Phase	Phase I
Variant Requirements	No
Sponsors	Eli Lilly and Company
Indications	lung non-small cell carcinoma ovarian cancer fallopian tube cancer triple-receptor negative breast cancer prostate cancer pancreatic cancer esophageal cancer cervical squamous cell carcinoma head and neck squamous cell carcinoma transitional cell carcinoma
Therapies	LY4101174
Age Groups:	adult \| senior
Covered Countries	USA \| FRA \| ESP \| BEL \| AUS

NCT06238479
Clinical Trial Detail